This Is MS Multiple Sclerosis Knowledge & Support Community

Physical disability may not be directly linked to brain lesions A recent study has found that physical disability may have no link to brain lesion volume in some patients with multiple sclerosis (MS)...Read more - http://www.ms-uk.org/physical-disability-may-not-be-directly-linked-brain-lesions-2306...

Scientists in Israel have discovered an abnormality in neurons’ protective membrane that may allow the body’s immune system to attack itself by mistake...Read more - http://www.ms-uk.org/scientists-discove ... -ms-200617

Researchers at Trinity College Dublin have developed four short, animated films about multiple sclerosis (MS). Now, they are looking for people living with MS, people who work with them, and their relatives, friends and loved ones to complete short surveys on each of the films in order to learn from...

A recent study has shown that MS is present long before the first symptoms start to appear. This period, in which an individual has MS without showing symptoms, is called the “prodromal stage” of MS...Read more - http://www.ms-uk.org/recent-study-says- ... gin-200617

Researchers have conducted a study into whether a high-salt diet is associated with faster conversion from clinically isolated syndrome (CIS) to multiple sclerosis (MS) MS activity and disability. This was measured by urinary sodium concentration...Read more - http://www.ms-uk.org/sodium-intake-not-...

Previously unpublished data may explain Lemtrada's efficacy and side effects Analysis of previously unpublished data from the pivotal phase III trials in the regulatory submissions of alemtuzumab, otherwise known as Lemtrada, indicated that efficiency was associated with long-term depletion of memor...

Sulbutiamine shows promising results in reducing fatigue in MS patients Researchers have conducted a study designed to evaluate the short-term effects of sulbutiamine in patients with multiple sclerosis (MS)...Read more - http://www.ms-uk.org/sulbutiamine-shows-promising-results-reducing-fatigue-ms-...

Hand grip strength could be used to assess the progression of MS After comparing changes in grip strength in people with multiple sclerosis (MS) to other assessment tools currently used, such as the timed 25-foot walk and Expanded Disability Status Scale (EDSS) score, researchers have found that han...

LIFNano is a simple and safe technology set to unlock new treatments for a number of neurodegenerative diseases. Founder of the technology, Dr Su Metcalfe believes it could well be the cure for MS we’ve all been waiting for...Read more - http://www.ms-uk.org/could-lifnano-be-new-breakthrough-treatme...

Research has found that children are 10 times more likely than adult patients to generate key proteins used to identify multiple sclerosis (MS). This means that a simple blood test could speed up the diagnosis of MS in childhood...Read more - http://www.ms-uk.org/blood-test-could-detect-childhood-ms...

Minocycline, a common acne drug, has been found to delay the progress of multiple sclerosis (MS) for patients in the early stages of the condition...Read more - http://www.ms-uk.org/acne-drug-slows-ms ... ent-010617

Investigation launched after Ocrevus patient develops rare brain infection It has been reported by Reuters, that Roche, the maker of Ocrevus, is investigating a case of patient illness after taking its drug...Read more - http://www.ms-uk.org/investigation-launched-after-ocrevus-patient-develops-rare...

A drug, proven to improve walking in people with MS, has been approved and given standard marketing authorisation by the European Commission (EC)...Read more - http://www.ms-uk.org/biogen%E2%80%99s-m ... ght-260517

In a phase III trial, 2,199 relapsing remitting multiple sclerosis (RRMS) patients were randomised to receive one of two doses of laquinimod or a placebo...Read more - http://www.ms-uk.org/laquinimod-fails-p ... nts-240517

Scientists have discovered an experimental treatment that targets activated immune cells, killing them off and stopping autoimmune damage...Read more - http://www.ms-uk.org/ppca-treatment-tem ... oms-230517